期刊文献+

三种去细胞方法构建的猪主动脉瓣膜支架的性能比较 被引量:8

Decellularized porcine aortic valve scaffolds created by different decellularization protocols: a comparison of their histological,biomechanical,and biocompatible characteristics
暂未订购
导出
摘要 目的:评价不同去细胞方法制备的猪主动脉瓣支架的组织学、生物力学特性及组织相容性,寻找更合适的去细胞心脏瓣膜支架制备方法。方法:分别采用3种不同的去细胞方法对新鲜猪主动脉瓣叶及带瓣主动脉管道进行脱细胞处理:0.01%胰蛋白酶+1%Triton+核酸酶组用含有0.01%胰蛋白酶-1%Triton和核酸酶的去细胞溶液37℃持续震荡24h;0.01%胰蛋白酶8h+1%脱氧胆酸(DCA)+核酸酶组先用0.01%胰蛋白酶37℃持续震荡消化处理8h,终止胰酶后加入含有1%DCA和核酸酶的去细胞溶液37℃持续震荡24h;1%DCA+核酸酶32h组:用含有1%DCA和核酸酶的去细胞溶液37℃持续震荡32h;同时以PBS漂洗的新鲜瓣叶作为对照组。通过H-E染色、扫描电镜和透射电镜观察评价去细胞效果。测定瓣叶弹性模量、最大抗张强度、应力伸长比及断裂伸长比以评价各组瓣叶的生物力学特性。大鼠皮下包埋实验评价去细胞支架的免疫源性、体内炎性反应及改建情况。结果:0.01%胰蛋白酶8h+1%DCA+核酸酶组细胞去除完全,优于0.01%胰蛋白酶+1%Triton+核酸酶组和1%DCA+核酸酶32h组。所制备瓣膜支架的弹性模量及最大抗张强度大于0.01%胰蛋白酶+1%Triton+核酸酶组。应力伸长比及断裂伸长比则小于0.01%胰蛋白酶+1%Triton+核酸酶组,与新鲜瓣叶无明显差异。体内埋植实验炎症反应轻微,宿主成纤维细胞能够长入支架并对其进行改建。结论:短时间低浓度胰蛋白酶与1%DCA和核酸酶相结合的去细胞法方便有效,既能完全去除猪带瓣主动脉管道的细胞成分,使免疫源性显著下降;同时瓣叶的生物力学特性保持稳定,可为受体细胞化组织工程心脏瓣膜的提供可靠的支架材料。 Objective: To compare the histological, immunological, and biomechanical characteristics of decellularized porcine aortic valve scaffold created by 3 different decellularization protocols and to search for a more suitable technique for creating aeellular tissue-engineered cardiac valve conduit. Methods: Porcine aortic valve leaflets and whole aortic roots were deeellularized by 3 different protocols. Decellularization procedure in group Ⅰ involved treatment with 0.01% trypsin, 1% Triton, and nuclease for 24 h; that in group Ⅱ involved treatment with 0.01% trypsin (8 h), 1% DCA, and nuclease for 24 h; and that in group Ⅲ involved treatment with 1% DCA and nuclease for 32 h. All the treatments were conducted during continuous shaking at 37℃. Porcine aortic valve leaflets and whole aortic roots treated with PBS were taken as control. The deeellularization efficiencies of each protocol were assessed by H-E staining, scanning electron microscopy, and transmission electron microscopy. The biomechanical features of the acellular valve matrices were examined by stress-strain tests and tensile strength tests. The immunogenicity and inflarfimatory responses of the decellularized matrices, valve leaflets, and aortic wall were investigated by subcutaneous implantation of them in rats. Results: The native ceils in porcine aortic valve leaflets and aortic roots were completely removed in group Ⅱ , which was superior to group Ⅰ and Ⅲ. The values of elasticity modulus and ultimate tensile strength (UTS) of groupⅡ were greater than those in group Ⅰ ([5.77±0. 951 MPa vs [4.15±1.13] MPa and [7.82± 1.51] MPa vs [4.65±0.85] MPa, respectively; P〈0.05). The extension ratios at 1.5 MPa and at rupture in group Ⅱ were less than those in group Ⅰ ([0.33±0.04] vs [-0.41±0. 091 and [-0.45±0. 021 vs [-0.60±0. 06]; P〈0.05), but the extension ratio at rupture was similar to that of fresh porcine aortic valves ( [0.45±0.02] vs ([-0.46±0.03]). Histological analysis showed only slight inflammatory responses in grouplland the host cells grew into the matrix, rebuilding the acellular matrices gradually. Conclusion: Decellularization using 8-hour pretreatment with 0. 01% trypsin, followed by 24 hours incubation with 1% DCA plus nuclease is effective and convenient; it not only removes the cells but also decreases the immunogenicity of the aortic valve matrices, making the product an excellent material for tissue-engineered cardiac valve conduit.
出处 《第二军医大学学报》 CAS CSCD 北大核心 2007年第1期8-12,共5页 Academic Journal of Second Military Medical University
关键词 组织工程 心脏瓣膜 人工 去细胞 猪主动脉瓣膜支架 tissue engineering heart valve prosthesis decellularization porcine aortic valve scaffolds
  • 相关文献

参考文献8

  • 1Vesely I,Lavin L G,Graf D.Mechanical testing of cryopreserved aortic allografts[J].J Thorac Cardiovasc Surg,1990,99:119-123.
  • 2Zeltinger J,Landeen L K,Alexander H G,et al.Development and characterization of tissue-engineered aortic valves[J].Tissue Eng,2001,7:9-22.
  • 3Booth C,Korossis S A,Wilcox H E,et al.Tissue engineering of cardiac valve prostheses Ⅰ:development and histological characterization of an acellular porcine scaffold[J].J Heart Valve Dis,2002,11:457-462.
  • 4Leyh R G,Wilhelmi M,Bebe P,et al.In vivo repopulation of xenogeneic and allogeneic acellular valve matrix conduits in the pulmonary circulation[J].Ann Thorac Surg,2003,75:1457-1463.
  • 5Simon P,Kasimir M T,Seebacher G,et al.Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients[J].Eur J Cardiothorac Surgery,2003,23:1002-1006.
  • 6Samouillan V,Dandurand-Lods J,Lamure A,et al.Thermal analysis characterization of aortic tissues for cardiac valve prostheses[J].J Biomed Mater Res,1999,46:531-538.
  • 7顾春虎,刘维永,刘洋,王云雅,张近宝,谭红梅,宿学家.不同试剂脱除猪主动脉瓣细胞的对比研究[J].中华胸心血管外科杂志,2006,22(2):127-129. 被引量:12
  • 8黄思远,徐志云,张宝仁,黄盛东,韩林,刘延玲.不同脱细胞方法对猪主动脉瓣的组织学及生物力学特性的影响[J].第二军医大学学报,2003,24(12):1293-1296. 被引量:6

二级参考文献13

  • 1Vesely I, Gonzalez-Lavin L, Graf D, et al. Mechanical testing of cryopreserved aortic allografts. Comparison with xenografts and fresh tissue [J].J Thorac Cardiovasc Surg, 1990.99 ( 1 ) :119-123.
  • 2Bader A,Schilling T,Teehken OE,et al. Tissue engineering of heart valves human endothelial cell seeding of detergent acellularized porcine valves[J]. Eur J Cardiothorac Surg , 1998,14(3):279-284.
  • 3Zehinger J, Landeen LK. Alexander HG, et al, Development and characterization of tissue engineered aortic valves[J]. Tissue Eng,2001,7(1):9-22.
  • 4Goldstein S, Clarke DR, Walsh SP, et al. Transpecies heart valve transplant :advanced studies of a bioengineered xeno-autograft [J]. Ann Thorac Surg,2000,70(6):1962-1969.
  • 5Courtman DW,Pereira CA,Kashef V.et al. Development of a pericardial acellular matrix biomaterial: biochemical and mechanical effects of cell extraction [J].J Biomed Mater Res,1994,28(6):655-666.
  • 6Allaire E,Bruneval P,Mandet C,et al. The immunogenicity of the extracellular matrix in arterial xenografts[J]. Surgery,1997,122(1):73-81.
  • 7Kim WG,Park JK,Lee WY.Tissue engineered heart valve leaflets:an effective method of obtaining acellularized valve xenografts.Int J Artif Organs,2002,25:791-797.
  • 8Walles T,Puschmann C,Haverich A,et al.A cellular scaffold implantation no alternative to tissue engineering.Int J Artif Organs,2003,26:225-234.
  • 9Booth C,Korossis SA,Wilcox HE,et al.Tissue engineering of cardia cvalve prostheses Ⅰ; development and histological characterization of an acellular porcine scaffold.J Heart Valve Dis,2002,11:457-462.
  • 10Kim WG,Park JK,Lee WY.Tissue-engineered heart valve leaflets:an effective method of obtaining acellularized valve xenografts.Int J Artif Organs,2002,25:791-797.

共引文献15

同被引文献88

引证文献8

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部